Markets:

Overview

News

Currencies

International

Treasuries

Evogene Ltd. - Ordinary Shares (NQ:EVGN)

0.6800 +0.0490 (+7.77%)

Streaming Delayed Price Updated: 11:27 AM EDT, Aug 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Evogene Ltd. - Ordinary Shares

< Previous 1 2 3 4 Next >

Evogene Offers An Excellent Risk/Reward Ratio ↗

March 21, 2023

We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine. Investors only need one of the company's subsidiaries to succeed, to de-risk their...

Via Talk Markets

Evogene 2022 Revenue Grows 80% To 1.7M ↗

March 09, 2023

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) 2022 revenue was $1.7 million, an increase of 80% compared to $930,000 in 2021. Q4 Financial Highlights

Via Benzinga

Evogene's Earnings Outlook ↗

March 08, 2023

Via Benzinga

Canonic Launches Six Second-Generation Cannabis Products With Higher THC And Rich Terpene Profiles ↗

February 21, 2023

Canonic Ltd., a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) launched six second-generation hybrid cannabis products in Israel.

Via Benzinga

Evogene Q3 Revenue Grows 208% YoY, Here Are The Details ↗

November 17, 2022

Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) Q3 2022 revenues were $466,000, a 208% increase in comparison to $151,000 in the same period of the previous year and were primarily due to revenues recognized...

Via Benzinga

Earnings Scheduled For November 17, 2022 ↗

November 17, 2022

Companies Reporting Before The Bell • Jumia Technologies (NYSE:JMIA) is expected to report quarterly loss at $0.76 per share on revenue of $57.32 million.

Via Benzinga

Preview: Evogene's Earnings ↗

November 16, 2022

Via Benzinga

Canonic Launches Its High THC Medical Cannabis Products In Israel ↗

September 21, 2022

Canonic Ltd., focused on the development of medical grade cannabis products and a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN), is launching its second-generation products in...

Via Benzinga

Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket ↗

September 06, 2022

Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday.

Via Benzinga

Evogene Q2 Revenue Grows 131% YoY, Here Is What You Need To Know ↗

August 31, 2022

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) Q2 2022 revenue was $312,000, an increase of 131% compared to $135,000 in the same period the previous year.

Via Benzinga

Earnings Scheduled For August 31, 2022 ↗

August 31, 2022

Companies Reporting Before The Bell • Hywin Holdings (NASDAQ:HYW) is expected to report earnings for its fourth quarter.

Via Benzinga

Recap: Evogene Q4 Earnings ↗

March 10, 2022

Evogene (NASDAQ:EVGN) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Earnings Outlook For Evogene ↗

August 30, 2022

Evogene (NASDAQ:EVGN) is set to give its latest quarterly earnings report on Wednesday, 2022-08-31. Here's what investors need to know before the announcement. Analysts estimate that Evogene will...

Via Benzinga

ADDING MULTIMEDIA ICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant Products

August 17, 2022

From ICL Group LTD

Via Business Wire

Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket ↗

August 17, 2022

Gainers Hill International, Inc. (NYSE: HIL) shares rose 58.1% to $2.75 in pre-market trading after the company agreed to be acquired by Global Infrastructure Solutions Inc. for $2.85 per share.

Via Benzinga

Earnings Scheduled For March 10, 2022 ↗

March 10, 2022

Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...

Via Benzinga

This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday ↗

July 22, 2022

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period...

Via Benzinga

Evogene Q1 Revenue Decreases 28.82% YoY, What About Debt? ↗

May 26, 2022

Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) released its financial results for the first quarter ended March 31, 2022, revealing revenue of $237,000 in comparison to $333,000 in the same period the...

Via Benzinga

Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session ↗

July 21, 2022

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending...

Via Benzinga

Evogene's Earnings: A Preview ↗

May 25, 2022

Evogene (NASDAQ:EVGN) is set to give its latest quarterly earnings report on Thursday, 2022-05-26. Here's what investors need to know before the announcement. Analysts estimate that Evogene will report...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

April 21, 2022

Rise and shine! We're gearing up for another busy day of trading with a breakdown of the biggest pre-market stock movers for Thursday!

Via InvestorPlace

Earnings Scheduled For May 26, 2022 ↗

May 26, 2022

Companies Reporting Before The Bell • American Woodmark (NASDAQ:AMWD) is likely to report quarterly earnings at $1.34 per share on revenue of $493.20 million.

Via Benzinga

26 Stocks Moving in Thursday's Pre-Market Session ↗

April 21, 2022

Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) rose 31.9% to $3.35 in pre-market trading after jumping around 25% on Wednesday. Clarus Therapeutics Holdings, Inc. (NASDAQ:...

Via Benzinga

Evogene Reports Wider Loss In 2021, $54M In Consolidated Cash ↗

March 10, 2022

Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN) announced its

Via Benzinga

A Preview Of Evogene's Earnings ↗

March 09, 2022

Evogene (NASDAQ:EVGN) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts estimate...

Via Benzinga

Medical-Grade Cannabis Developer Canonic Appoints Ex-SEO At Israeli Ministry Of Health To Its Board ↗

February 16, 2022

Medical-grade cannabis developer Canonic Ltd., and a wholly-owned subs...

Via Benzinga

Computational Biology Company Evogene Confirms Earnings Results Release Date ↗

February 15, 2022

Computational biology company Evogene Ltd. (NASDAQ:EVGN)&n...

Via Benzinga

Evogene's Canonic Ships First Batch Of Unique Cannabis Varieties To Europe ↗

January 31, 2022

Medical grade cannabis products developer Canonic Ltd. and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), has shipped the first batch of its unique cannabis varieties to Portugal, following...

Via Benzinga

Certain Marijuana Varieties Have 'Impressive' Pain Relief Properties, Evogene's Cannonic's Pre-Clinical Study Confirms ↗

January 18, 2022

Medical grade cannabis products developer Canonic Ltd., a subsidiary of Evogene Ltd. (NASDAQ:

Via Benzinga

Potential Cannabis Unicorn "InterCure" Realizes the 7th Consecutive Quarter of Revenue Growth ↗

December 01, 2021

Former prime minister of Israel and InterCure chairman Ehud Barak at the company’s market open from their cultivation site in Israel...

Via Benzinga

Topics Cannabis

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.